Rare diseases often leave patients, healthcare professionals, and pharma companies navigating complex challenges, from limited treatment options to high costs and difficult clinical trial development. Cell and gene therapies (CGT) offer a unique opportunity to address these challenges by treating diseases at their genetic or cellular roots. In this webinar, sponsored by IPG Health, discover how industry insiders are unlocking the potential of CGT in rare disease care, the unique hurdles facing pharma and patients, and the transformative opportunities these therapies bring.